KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Current Deferred Revenue (2016 - 2026)

Moderna (MRNA) has disclosed Current Deferred Revenue for 11 consecutive years, with $256.0 million as the latest value for Q1 2026.

  • For Q1 2026, Current Deferred Revenue rose 104.8% year-over-year to $256.0 million; the TTM value through Mar 2026 reached $256.0 million, up 104.8%, while the annual FY2025 figure was $252.0 million, 19.43% up from the prior year.
  • Current Deferred Revenue hit $256.0 million in Q1 2026 for Moderna, up from $252.0 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $6.1 billion in Q1 2022 and bottomed at $20.0 million in Q2 2024.
  • Average Current Deferred Revenue over 5 years is $1.5 billion, with a median of $568.0 million recorded in 2023.
  • Year-over-year, Current Deferred Revenue tumbled 98.08% in 2024 and then soared 1315.0% in 2025.
  • Moderna's Current Deferred Revenue stood at $2.7 billion in 2022, then tumbled by 79.05% to $568.0 million in 2023, then plummeted by 62.85% to $211.0 million in 2024, then grew by 19.43% to $252.0 million in 2025, then rose by 1.59% to $256.0 million in 2026.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $256.0 million, $252.0 million, and $320.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.